Paragon 28 Inc. (FNA)
undefined
undefined%
At close: undefined
10.42
0.43%
After-hours Dec 13, 2024, 04:10 PM EST

Company Description

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally.

It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.

The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis.

In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot.

Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application.

Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments.

The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors.

Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Paragon 28 Inc.
Paragon 28 Inc. logo
Country United States
IPO Date Oct 15, 2021
Industry Medical - Devices
Sector Healthcare
Employees 574
CEO Albert DaCosta

Contact Details

Address:
14445 Grasslands Drive
Englewood, Colorado
United States
Website https://www.paragon28.com

Stock Details

Ticker Symbol FNA
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001531978
CUSIP Number 69913P105
ISIN Number US69913P1057
Employer ID 27-3170186
SIC Code 3841

Key Executives

Name Position
Albert DaCosta Co-Founder, Chairman, President & Chief Executive Officer
Chadi Chahine Chief Financial Officer & Executive Vice President of Supply Chain Operations
Andrew James Hill Executive Vice President of Research & Development
Brendan Shook Executive Vice President of Marketing & Medical Education
Dr. Matthew Millard Chief Human Resources Officer
Hans Kestler Executive Vice President of International
John Shumaker Executive Vice President of Sales - U.S.
Matthew Brinckman Senior Vice President of Strategy & Investor Relations
Matthew Jarboe Executive Vice President of Sales & Chief Commercial Officer
Robert S. McCormack J.D. General Counsel & Secretary

Latest SEC Filings

Date Type Title
Dec 12, 2024 4 Filing
Dec 12, 2024 3 Filing
Dec 11, 2024 8-K Current Report
Dec 10, 2024 4 Filing
Dec 10, 2024 4 Filing
Dec 06, 2024 4 Filing
Nov 29, 2024 4 Filing
Nov 26, 2024 4 Filing
Nov 22, 2024 4 Filing
Nov 15, 2024 4 Filing